![Pharmacology / Monoclonal antibodies / Adalimumab / Autoimmune diseases / Rheumatoid arthritis / Latent tuberculosis / Disease-modifying antirheumatic drug / Biologic / Placebo / Medicine / Immunosuppressants / Immunology Pharmacology / Monoclonal antibodies / Adalimumab / Autoimmune diseases / Rheumatoid arthritis / Latent tuberculosis / Disease-modifying antirheumatic drug / Biologic / Placebo / Medicine / Immunosuppressants / Immunology](https://www.pdfsearch.io/img/693057286307bb236741cc5de41aab3a.jpg)
| Open Document File Size: 69,55 KBShare Result on Facebook
Company Ames / / Facility American College of Rheumatology / / IndustryTerm drug product / phage display technology / preservative-free solution / / MedicalCondition anaphylactic reaction / demyelinating disease / allergic reaction / pneumonia / latent tuberculosis infection / lymphoma / disease / Carcinogenesis / bronchitis / rheumatoid arthritis / chronic / demyelinating disorders / erythema / itching / fever / respiratory tract infections / human tumor necrosis factor / pathologic inflammation / normal inflammatory and immune responses / hypersensitivity / infection / urinary tract infections / active rheumatoid arthritis / cough / inflammation / depression / INFECTIONS / rash / syndrome / tuberculosis / / MedicalTreatment Immunosuppression / Immunizations / vaccination / / Organization HUMIRA administration / World Health Organization / American College of Rheumatology / Centers for Disease Control and Prevention / / Person Tuberculosis As / / Position Physician / General / pH. CLINICAL PHARMACOLOGY General / / Product HUMIRA / sodium chloride / mannitol / / Technology alpha / Pharmacokinetics / X-ray / antibodies / Pharmacodynamics / recombinant DNA technology / using phage display technology / /
SocialTag |